Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.

Background: Despite available treatment with intravenous immunoglobulin (IVIg), morbidity and mortality are considerable in patients with Guillain-Barré syndrome (GBS). Our aim was to assess whether methylprednisolone, when taken with IVIg, improves outcome when compared with IVIg alone.Methods: We...

Full description

Bibliographic Details

Published in:	Lancet Vol. 363; no. 9404; pp. 192 - 197
Main Authors:	van Koningsveld R, Schmitz PIM, van der Meché FGA, Visser LH, Meulstee J, van Doorn PA, van Koningsveld, R, Schmitz, P I M, Meché, F G Avander, Visser, L H, Meulstee, J, van Doorn, P A
Format:	clinical trial research tables/charts Journal Article
Published:	Lancet 1/17/2004
Online Access:	View this record in EBSCOhost